(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the following statement in response to a recent study published in Environment International regarding the presence of metals in certain tampon products. The study did not assess the risk of metal exposure to tampon users.
Consumer trust is a responsibility CHPA member companies take very seriously, and their commitment to ensuring consumer safety remains the top priority. Our members strictly adhere to Current Good Manufacturing Practices (CGMPs) outlined in the Federal Food, Drug and Cosmetic Act (FDCA) and abide by all regulations, guidelines, and procedures set forth by the U.S. Food and Drug Administration (FDA).
Consumer healthcare products are rigorously tested to meet these strict regulatory standards. Before tampons can be legally marketed in the United States, they must undergo FDA’s review process. Manufacturers are required to submit data, including results evaluating the safety of the materials used to make the tampons and applicators, demonstrating that they can be safely used in or on the human body.
This study did not assess if any metals are released from tampons in real world use conditions and did not document any health risks to tampon users. FDA stated that it has commissioned an independent literature review and an internal laboratory study and will share peer-reviewed data when available. CHPA is supportive of continued research to help ensure the safe use of these products.
